Co-Founder, President & CEO, S&R Foundation

Sachiko Kuno

Dr. Sachiko Kuno is a committed scientist, philanthropist, and entrepreneur whose mission is to empower others to change the world by providing the support needed to advance their innovative ideas. Currently she acts as President and CEO of S&R Evermay and serves on the Board of Directors for numerous organizations including DeNA and Monex Group, Inc. She also serves as Adjunct Professor at Kyoto University. Within her career, Dr. Kuno has launched Halcyon Incubator (which has three fellows in attendance tonight) and co-founded WE Capital, Phoenixi Co. Inc, R-Tech Ueno, Ltd. (Japan) Sucampo Pharmaceuticals (U.S.) (sold in 2018), and VLP Therapeutics (U.S).  She has also successfully developed and commercialized two pharmaceutical products.